Evidence map›Paper›PMID 17965767›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2007

Indigofera suffruticosa: an alternative anticancer therapy.

Jeymesson Raphael Cardoso Vieira, Ivone Antônia de Souza, Silene Carneiro do Nascimento, Sônia Pereira Leite

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Advances in pharmacological sciences · 2018
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo.Evidence-based complementary and alternative medicine : eCAM · 2011
    Article
  8. Article
  9. Article
  10. Mutagenic Activity of Indigofera truxillensis and I. suffruticosa Aerial Parts.Evidence-based complementary and alternative medicine : eCAM · 2011
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jeymesson Raphael Cardoso VieiraUniversidade Federal de Pernambuco/Departamento de Patologia do Centro de Ciências da Saúde Recife-PE, Brazil.
Ivone Antônia de Souza
Silene Carneiro do Nascimento
Sônia Pereira Leite

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Indigofera suffruticosa Mill (Fabeceae) occurs in the Northeast countryside and has intensive popular use in the treatment of infectious, inflammatory and other processes. The main aim of the present work was to investigate the cytotoxic and antitumor effects of aqueous extracts of leaves of I. suffruticosa obtained by infusion and maceration as well as to evaluate the toxicological properties. Aqueous extracts did not exhibit cytotoxicity against HEp-2 (human epidermoid cancer cell) cell lines by MTT method. From the aqueous extract by infusion, the toxicological assay showed low order of toxicity. The antitumor effect of aqueous extracts by infusion (64.53%) and maceration (62.62%) against sarcoma 180 in mice at a dose of 50 mg kg(-1) (intraperitoneally), based on low order of toxicity was comparable to the control group, which showed 100% development. Considering the low order of toxicity and that it is highly effective in inhibiting growth of solid tumors, the aqueous extracts of leaves of I. suffruticosa may be used as an alternative anticancer agent.

Indexed as

antitumoraqueous extractcytotoxicityIndigofera suffruticosatoxicity

Identifiers

PMID17965767
PMCPMC1978235

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.